undamentalytics Newsletter
Sign in

IDEX Corporation (IEX) stock

Add to watchlist

Add holding +

NYSE: IEX NYSE Industrial Machinery & Supplies & Components Next results ~February 3, 2027

B Fundamentals grade

IDEX Corporation is a US-listed company in the industrial machinery & supplies & components industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$160

Cash-flow model

Base case. Range ~$110–$210 across our lower- and higher-growth cases (0.2%–10.2% a year).

Price vs value

Overvalued

The price is above our entire value range; our base value is 33% below it.

Price used: $236.52, November 2, 2026

IDEX Corporation valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders1 buying, 2 selling1 purchase and 3 sales by directors and officers, last 12 monthsInsider trades
  • Funds329 adding, 275 cuttingOf 80 active managers that changed their stake, 37 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter IDEX files

10-Q filed October 28: IDEX

Model value +2.9%

Revenue for the twelve months to September 2026 was $3.66bn, up 6.9% on a year earlier, about the same pace as a quarter earlier. Free-cash-flow margin rose to 18.2% from 17.1% a year earlier. Our model value rises from $153 to $157 a share, against a share price of $240. The rating stays Sell. At that price, our model says the market is pricing in about 12.2% a year of cash-flow growth for five years, faster than the 5.8% a year revenue growth it has delivered.

Source: 10-Q filed October 28, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (2)

10-Q filed July 29: IDEX

IDEX Corporation generated $3.66bn in revenue over the twelve months to June 2026, a rise of 6.9% on the prior year and roughly the same pace as the quarter before. Free-cash-flow margin improved too, climbing to 18.2% from 17.1% a year earlier. That progress nudges the fundamentals grade from C to C+. Our model value, however, barely moved, sitting at $153 a share against a market price of $233. The Sell rating is unchanged. At the current price, the market appears to be pricing in cash-flow growth of about 12.3% a year for the next five years, well above the 5.8% annual revenue growth IDEX has actually delivered. The gap between valuation and fundamentals remains wide.

10-Q on SEC EDGAR

Where IDEX stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.59bn, up 7.3% on a year earlier, about the same pace as a quarter earlier. Free-cash-flow margin held at 17.9%. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 2 of our 6 financial-health checks. Our cash-flow model value is $151 a share, against a share price of $232. At that price, our model says the market is pricing in about 12.0% a year of cash-flow growth for five years, faster than the 5.3% a year revenue growth it has delivered.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 3, 2027 (estimated)

IDEX Corporation's trailing-twelve-month revenue grew 6.9% year on year, with a free-cash-flow margin of 18.2%. Where it stands out: free-cash-flow margin of 18.2% ranks 11 of 76 industrial machinery & supplies & components companies we cover.

Our discounted-cash-flow model values the business at ~$160 per share in the base case (~$110–$210 across growth scenarios) — model values under stated assumptions, not a price target.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 1.7% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Priced above our value. The share price of $236.52 is 33% above our value per share of $160.

Latest results: FY2026 Q3

Filed October 28, 2026
Earnings per share
$2.33 against an average estimate of $2.24: beat by 4.0%
Revenue
$952m, up 8.3% on a year earlier
Share reaction
+2.6% in the first session after the results on October 28, 2026, against 0.0% for the S&P 500
Guidance given
full year organic sales growth growth 6.5% to 6.8% (full year); full year adjusted diluted EPS $8.91 to $8.96 (full year)
Next report
October 28, 2026; average EPS estimate $2.30

IDEX's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+1.1%
  • 1 week+2.4%
  • 1 month+1.5%
  • This year+34.7%
  • 1 year+39.8%
  • 5 years+9.6%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.7B
Operating margin
20.9%
Net margin
14.6%
EPS (TTM, diluted)
$7.21

Growth

Revenue growth
+6.9%
Change in growth rate
−0.4 pts
Share count change
−1.7%

Cash

Free cash flow (TTM)
$667M
FCF margin
18.2%
Stock pay % of revenue
0.9%

Earnings

Last results
October 28, 2026
Next results (est.)
February 3, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Guidance
  3. Dividend
  4. Agreement
  5. Leadership
  6. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

IDEX Corporation valuation models and calculator

What the price is pricing in

The share price implies about 12.1% a year of cash-flow growth for five years.That is faster than the 5.8% a year revenue growth IDEX has delivered.

  • Priced in12.1%
  • Last 12 months6.9%
  • 3 years a year3.5%
  • 5 years a year5.8%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($237.65, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Sell12-month view
12-month price target
~$160
Price used
$237.65close November 3, 2026
Implied change
▼ 34%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of IDEX Corporation's free cash flow after stock-based pay with after-tax interest added back ($636M, FY2026 Q3 TTM), growing 5.9% and 5.4% in the next two years (forecasts, guidance and its record), then back to 5.2% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$110–~$210 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of IDEX Corporation's free cash flow after stock-based pay ( $636M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value IDEX Corporation as an operating company, with every model that fits that kind of business. Cost of equity 9.3%: the 10-year Treasury yield (4.9%) plus a beta of 0.97 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$160 ~$110–$210 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$170 ~$150–$220 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$100 ~$77–$140 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$110 ~$96–$130 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$140 ~$100–$170 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare IDEX Corporation with Industrial Machinery & Supplies & Components in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −27%
  • Revenue growth 5 points higher ▲ +35%
  • Free-cash-flow margin 1 point lower ▼ −6%
  • Last year's free-cash-flow margin change, if it persists ▲ +7%
  • Discount rate 1 point higher ▼ −16%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $109$153$212$289$390$521
8.5% $79$112$154$209$281$374
10% $62$87$119$162$217$287

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$66.49$79.46$118.02$114.29$157.65$184.80$221.42$216.50$208.28$203.37$175.53$236.52
Market value$5.2bn$6.1bn$9.1bn$8.9bn$12.1bn$14.1bn$16.9bn$16.5bn$15.8bn$15.4bn$13.2bn$17.6bn
+ Net debt (− = net cash)$521m$786m$486m$385m$218m$24m$345m$1.0bn$799m$1.4bn$1.2bn$1.2bn
Enterprise value$5.7bn$6.9bn$9.6bn$9.2bn$12.3bn$14.1bn$17.3bn$17.5bn$16.6bn$16.8bn$14.5bn$18.7bn
Multiples
Price / sales 2.6x2.9x4.0x3.6x4.8x6.0x6.1x5.2x4.8x4.7x3.8x4.8x
Price / earnings 18.3x22.5x27.1x21.6x28.3x37.4x37.6x28.0x26.5x30.6x27.4x32.8x
Price / free cash flow 16.4x16.9x23.5x20.9x25.3x27.3x34.3x33.6x25.2x25.6x21.4x26.4x
EV / EBITDA 11.1x13.8x16.4x14.3x18.7x23.4x23.3x20.1x18.8x22.5x18.7x22.2x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

83 /100

Strong moat

How hard IDEX's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 14 / 20

    Net income has been a median 9.0% of total assets over 10 years.

  • Pricing power 15 / 20

    Gross margin has been a median 44.6%, moving by 0.5 percentage points (standard deviation) across 10 years.

  • Durability 17 / 20

    Operating margin has been a median 22.3%; its worst year was 19.9%.

  • Cash conversion 19 / 20

    Free cash flow was positive in 10 of 10 years, at a median 18.1% of revenue.

  • Discipline 18 / 20

    The diluted share count fell 2.7% over five years; stock-based pay has been a median 0.9% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $8.95 +13% $3.7bn +8%
Next $9.74 +9% $3.9bn +6%

Next year's EPS estimate has moved +2.9% in 90 days, across 15 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +1.4% on 90 days ago. In the last 30 days, 1 analyst raised IDEX Corporation's forecast and 0 cut it.

Consensus EPS forecast IDEX Corporation, last 90 days
$8.50 $9.00 $9.50 $10.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $8.82 Current fiscal year, 60 days ago: $8.82 Current fiscal year, 30 days ago: $8.83 Current fiscal year, 7 days ago: $8.83 Current fiscal year, Now: $8.95 $8.95 Next fiscal year, 90 days ago: $9.46 Next fiscal year, 60 days ago: $9.58 Next fiscal year, 30 days ago: $9.63 Next fiscal year, 7 days ago: $9.64 Next fiscal year, Now: $9.74 $9.74

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $8.82$9.46
60 days ago $8.82$9.58
30 days ago $8.83$9.63
7 days ago $8.83$9.64
Now $8.95$9.74

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $2.24 $2.33 +4.0%
Jun 2026 $2.11 $2.32 +9.9%
Mar 2026 $1.77 $2.00 +12.8%
Dec 2025 $2.04 $2.10 +2.9%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 28, 2026
  • Full year organic sales growth full year 6.5% growth to 6.8% growth Non-GAAP Raised
    “Full year organic sales projected to increase 6.5% to 6.8% over the prior year, up from previous guidance of 5% to 6%” source
  • Full year adjusted diluted EPS full year $8.91 to $8.96 Non-GAAP Raised
    “Full year adjusted diluted EPS of $8.91 to $8.96, up approximately 12% year-over-year at midpoint, up from previous guidance of $8.70 to $8.85” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows IDEX Corporation's revenue by +5.9% next year and +5.4% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+6.2%, weight 68%) and the company's own record (+5.2%, weight 32%) . How the weights are set.

Analyst recommendations

15 analysts, Oct 2026
Buy1067%
Hold533%
Sell00%

Monthly trend

  1. Oct 20269515
  2. Sep 20269515
  3. Aug 20268615
  4. Jul 20267715

Counts of recommendations published by analysts covering IDEX Corporation, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
3.9%
of tradable shares
Days to cover
3.72
at average volume
Short interest, 1 month
+19%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.2%
of shares
Employees
8,700
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +39.8%

$169.14 on October 31, 2025 to $236.52

ThenNowEffect
Revenue (last 12 months) $3.3bn $3.6bn +7.3%
Net margin 14.1% 14.5% +3.1%
P/E multiple 27.3x 34.0x +24.4%
Share count 76m 75m +1.5%

Biggest factor: p/e multiple.

Last 3 years +26.3%

$187.23 on November 3, 2023 to $236.52

ThenNowEffect
Revenue (last 12 months) $3.3bn $3.6bn +7.8%
Net margin 17.7% 14.5% −17.9%
P/E multiple 24.2x 34.0x +40.5%
Share count 76m 75m +1.6%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
IEX+20%−2%−4%−2%−14%+35%
Industry peers (median)+19%−15%+21%+2%+13%+3%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
IEX58%33%58%50%50%64%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
IEX−11%−26%−21%−22%−29%−15%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 36% from February 12, 2020 to March 18, 2020. Getting back needed a 55% gain, reached on August 12, 2020, 147 days after the low.

Price behaviour

52-week range
$159.49 – $239.76
From 52-week high
−1.3%
vs 50-day average
+2.9%
vs 200-day average
+9.9%
Volatility (1 year)
22%
Beta vs S&P 500
0.68

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
8 up, 4 down
typical move ±5.4%
After a week
7 up, 4 down
typical move ±7.1%
After a month
6 up, 5 down
typical move ±6.5%
Results releasedNext dayS&P 500 next day5 days21 days
October 28, 2026 +2.6% 0.0% — —
July 29, 2026 +4.1% +0.1% +5.5% +4.2%
April 29, 2026 +6.1% +1.0% +6.2% +3.0%
February 4, 2026 +5.6% −1.7% +4.9% −1.8%
October 29, 2025 +2.0% −1.1% +0.8% +4.2%
July 30, 2025 −11.7% −0.5% −13.7% −10.8%
May 1, 2025 +4.3% +2.2% +6.1% +3.4%
February 4, 2025 −9.7% +1.1% −11.0% −14.3%
October 30, 2024 +5.3% −2.3% +15.2% +13.1%
August 1, 2024 −6.9% −3.3% −6.5% −1.0%
April 24, 2024 −3.9% −0.4% −4.7% −6.9%
February 7, 2024 +3.2% +0.9% +3.7% +9.0%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

IDEX Corporation in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) IDEX Corporation
$3B $3.2B $3.4B $3.6B $3.8B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $3.3B Revenue (TTM), FY24 Q1: $3.2B Revenue (TTM), FY24 Q2: $3.2B Revenue (TTM), FY24 Q3: $3.2B Revenue (TTM), FY24 Q4: $3.3B Revenue (TTM), FY25 Q1: $3.3B Revenue (TTM), FY25 Q2: $3.3B Revenue (TTM), FY25 Q3: $3.4B Revenue (TTM), FY25 Q4: $3.5B Revenue (TTM), FY26 Q1: $3.5B Revenue (TTM), FY26 Q2: $3.6B Revenue (TTM), FY26 Q3: $3.7B $3.7B

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $3.3B
FY24 Q1 $3.2B
FY24 Q2 $3.2B
FY24 Q3 $3.2B
FY24 Q4 $3.3B
FY25 Q1 $3.3B
FY25 Q2 $3.3B
FY25 Q3 $3.4B
FY25 Q4 $3.5B
FY26 Q1 $3.5B
FY26 Q2 $3.6B
FY26 Q3 $3.7B
Revenue growth, TTM YoY IDEX Corporation
-5% 0% 5% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 2.9% Revenue growth, TTM YoY, FY24 Q1: -1.4% Revenue growth, TTM YoY, FY24 Q2: -4.1% Revenue growth, TTM YoY, FY24 Q3: -3.1% Revenue growth, TTM YoY, FY24 Q4: -0.2% Revenue growth, TTM YoY, FY25 Q1: 1.7% Revenue growth, TTM YoY, FY25 Q2: 4.7% Revenue growth, TTM YoY, FY25 Q3: 7.1% Revenue growth, TTM YoY, FY25 Q4: 5.8% Revenue growth, TTM YoY, FY26 Q1: 7.5% Revenue growth, TTM YoY, FY26 Q2: 7.3% Revenue growth, TTM YoY, FY26 Q3: 6.9% 6.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 2.9%
FY24 Q1 -1.4%
FY24 Q2 -4.1%
FY24 Q3 -3.1%
FY24 Q4 -0.2%
FY25 Q1 1.7%
FY25 Q2 4.7%
FY25 Q3 7.1%
FY25 Q4 5.8%
FY26 Q1 7.5%
FY26 Q2 7.3%
FY26 Q3 6.9%
Operating margin (TTM) IDEX Corporation
19% 20% 21% 22% 23% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 22.4% Operating margin (TTM), FY24 Q1: 21.7% Operating margin (TTM), FY24 Q2: 21.4% Operating margin (TTM), FY24 Q3: 21.0% Operating margin (TTM), FY24 Q4: 20.7% Operating margin (TTM), FY25 Q1: 20.0% Operating margin (TTM), FY25 Q2: 19.9% Operating margin (TTM), FY25 Q3: 19.9% Operating margin (TTM), FY25 Q4: 20.2% Operating margin (TTM), FY26 Q1: 20.7% Operating margin (TTM), FY26 Q2: 20.7% Operating margin (TTM), FY26 Q3: 20.9% 20.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 22.4%
FY24 Q1 21.7%
FY24 Q2 21.4%
FY24 Q3 21.0%
FY24 Q4 20.7%
FY25 Q1 20.0%
FY25 Q2 19.9%
FY25 Q3 19.9%
FY25 Q4 20.2%
FY26 Q1 20.7%
FY26 Q2 20.7%
FY26 Q3 20.9%
FCF margin (TTM) IDEX Corporation
16% 17% 18% 19% 20% 21% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 19.1% FCF margin (TTM), FY24 Q1: 19.9% FCF margin (TTM), FY24 Q2: 20.1% FCF margin (TTM), FY24 Q3: 19.6% FCF margin (TTM), FY24 Q4: 18.4% FCF margin (TTM), FY25 Q1: 17.0% FCF margin (TTM), FY25 Q2: 17.6% FCF margin (TTM), FY25 Q3: 17.1% FCF margin (TTM), FY25 Q4: 17.8% FCF margin (TTM), FY26 Q1: 17.3% FCF margin (TTM), FY26 Q2: 17.9% FCF margin (TTM), FY26 Q3: 18.2% 18.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 19.1%
FY24 Q1 19.9%
FY24 Q2 20.1%
FY24 Q3 19.6%
FY24 Q4 18.4%
FY25 Q1 17.0%
FY25 Q2 17.6%
FY25 Q3 17.1%
FY25 Q4 17.8%
FY26 Q1 17.3%
FY26 Q2 17.9%
FY26 Q3 18.2%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 1,330 1,513 1,838 1,954 2,024 2,148 2,021 2,113 2,287 2,484 2,495 2,352 2,765 3,182 3,274 3,269 3,458 3,658
Gross profit 522 618 739 804 873 949 904 931 1,027 1,118 1,125 1,027 1,225 1,427 1,447 1,445 1,539 1,642
EBITDA 241 307 377 207 475 508 515 499 587 647 656 604 740 871 885 746 775 844
Operating income 185 249 305 128 396 431 437 412 503 569 579 521 637 751 733 677 699 764
Net income 113 157 194 38 255 279 283 271 337 411 426 378 449 587 596 505 483 536
Diluted EPS $1.40 $1.90 $2.32 $0.45 $3.09 $3.45 $3.62 $3.53 $4.36 $5.29 $5.56 $4.94 $5.88 $7.71 $7.85 $6.64 $6.41 $7.21
Growth (year on year)
Revenue −10.7% +13.8% +21.5% +6.3% +3.6% +6.1% −5.9% +4.6% +8.2% +8.6% +0.4% −5.7% +17.6% +15.1% +2.9% −0.2% +5.8% +6.9%
EBITDA +1.8% +27.4% +22.7% −45.2% +129.9% +7.0% +1.4% −3.1% +17.5% +10.2% +1.4% −7.9% +22.5% +17.7% +1.5% −15.7% +3.9% +23.9%
Operating income −10.2% +34.8% +22.3% −57.9% +208.5% +9.0% +1.3% −5.6% +21.9% +13.2% +1.7% −10.1% +22.3% +18.0% −2.5% −7.5% +3.3% +12.2%
Net income −10.7% +38.5% +23.4% −80.6% — +9.5% +1.2% −4.1% +24.4% +21.7% +3.6% −11.2% +19.0% +30.6% +1.6% −15.3% −4.3% +12.1%
Diluted EPS −8.5% +35.7% +22.1% −80.6% — +11.7% +4.9% −2.5% +23.5% +21.3% +5.1% −11.2% +19.0% +31.1% +1.8% −15.4% −3.5% +14.0%
Margins
Gross margin 39.3% 40.9% 40.2% 41.1% 43.1% 44.2% 44.8% 44.0% 44.9% 45.0% 45.1% 43.7% 44.3% 44.8% 44.2% 44.2% 44.5% 44.9%
EBITDA margin 18.1% 20.3% 20.5% 10.6% 23.5% 23.7% 25.5% 23.6% 25.7% 26.0% 26.3% 25.7% 26.8% 27.4% 27.0% 22.8% 22.4% 23.1%
Operating margin 13.9% 16.5% 16.6% 6.6% 19.5% 20.1% 21.6% 19.5% 22.0% 22.9% 23.2% 22.1% 23.0% 23.6% 22.4% 20.7% 20.2% 20.9%
Net margin 8.5% 10.4% 10.5% 1.9% 12.6% 13.0% 14.0% 12.8% 14.7% 16.5% 17.1% 16.1% 16.3% 18.4% 18.2% 15.4% 14.0% 14.6%
Free-cash-flow margin 14.1% 10.1% 9.9% 14.9% 18.3% 14.9% 15.7% 17.1% 17.0% 17.0% 19.1% 22.0% 17.8% 15.4% 19.1% 18.4% 17.8% 18.2%
Cash flow
Cash from operations 213 184 217 326 402 368 360 400 433 479 528 569 565 557 717 668 680 753
Capital spending 25 32 35 36 32 48 44 38 44 56 51 52 73 68 90 65 64 86
Free cash flow 187 153 182 290 370 320 317 362 389 423 477 518 493 489 627 603 617 667
Stock-based pay 16 17 12 13 17 21 20 20 24 25 22 15 20 22 22 26 27 35
Free cash flow after stock pay 172 135 170 277 353 299 296 341 364 399 455 503 472 468 605 577 590 633
Balance sheet
Cash 74 235 230 319 440 509 328 236 376 466 633 1,026 855 430 534 621 580 602
Total debt 400 647 811 794 776 965 849 1,022 862 852 851 1,050 1,200 1,478 1,333 1,971 1,830 1,759
Net debt (negative = net cash) 327 412 581 475 336 455 521 786 486 385 218 24 345 1,048 799 1,351 1,250 1,157
Diluted shares 81m 82m 84m 84m 82m 81m 78m 77m 77m 78m 77m 76m 76m 76m 76m 76m 75m 74m
Returned to shareholders
Dividends 39 46 55 64 73 86 96 103 111 127 147 152 161 177 191 205 213 214
Buybacks — — 0 90 168 220 211 57 29 174 55 110 0 148 24 0 248 301
Total returned 39 46 55 154 240 306 307 160 140 301 202 262 161 326 215 205 460 515

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 6 checks passed · September 30, 2026
What it owns · $6.9bn
Short-term assets $1.8bnLonger-term assets $5.1bn
What it owes, and who funded it · $6.9bn
Short-term liabilities $636mLonger-term liabilities $2.2bnShareholders' equity $4.0bn
  • Short-term assets cover short-term liabilities $1.8bn of assets due within a year against $636m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.8bn short-term assets against $2.2bn of longer-dated liabilities.
  • More cash than debt $602m of cash against $1.8bn of debt.
  • Debt below 40% of shareholders' equity Debt is 44% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 41% to 44% over five years.
  • A year's operating cash flow covers at least 20% of debt $753m of operating cash flow against $1.8bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From IDEX Corporation's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$301M
Dividends (TTM)
$214M
Returned to shareholders
77%
of free cash flow
Buybacks, last 3 fiscal years
$272M
Diluted share count
−1.7%
year over year
Total shareholder yield
2.9%
dividends 1.2% + buybacks 1.7% of market value
Dividend payout ratio
40%
of net income paid out
Sales & admin spending
23.6%
of revenue
Days sales outstanding
54 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in industrial machinery & supplies & components
Last 12 months unless stated IEX GTES DCI JBTM MIDD PNR Median
Revenue, last 12 months $3.7bn $3.6bn $3.9bn $3.9bn $3.4bn $4.0bn $1.4bn
Revenue growth, last 12 months 6.9% 4.0% 5.3% 44.9% 8.4% −3.9% 8.3%
Revenue growth, 3-year average 3.5% −0.4% 4.2% 34.0% −5.9% −1.3% 4.0%
Revenue growth, latest quarter 8.3% 5.6% 8.0% 4.9% 9.9% −4.5% 9.1%
Gross margin 44.9% 40.3% 34.6% 35.6% 38.4% 41.2% 35.2%
Operating margin 20.9% 13.5% 15.4% 7.3% 16.5% 19.6% 13.1%
Operating margin, 3-year average 20.6% 13.8% 14.7% 6.3% 19.5% 19.7% 13.7%
Net margin 14.6% 10.4% 11.7% 4.9% −13.9% 15.4% 8.9%
Cash from operations / revenue 20.6% 12.4% 12.7% 10.8% 15.6% 18.3% 11.9%
Free-cash-flow margin 18.2% 10.3% 11.0% 7.9% 14.2% 16.3% 8.8%
Free-cash-flow margin, 3-year average 18.3% 9.5% 10.5% 6.2% 20.1% 17.7% 9.8%
Stock pay / revenue 0.9% 0.8% 0.6% 0.8% 0.7% 0.8% 0.8%
Change in share count −1.7% −1.7% −2.1% 24.0% −10.5% −2.0% −0.0%

Median of all 76 companies we cover in industrial machinery & supplies & components. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

76 industrial machinery & supplies & components companies
Measure Company Peer median Rank
Revenue growth Growth 6.9% 8.3% 48 of 75
Change in growth rate Growth -0.4pp +1.2pp 55 of 75
Gross margin Profitability 44.9% 35.4% 11 of 70
Operating margin Profitability 20.9% 13.0% 11 of 75
Net margin Profitability 14.6% 8.9% 16 of 76
Free-cash-flow margin Cash generation 18.2% 9.1% 11 of 76
Stock pay as % of revenue Cash generation 0.9% 0.8% 45 of 70
Long-term debt as % of assets Balance sheet 25.5% 23.4% 35 of 59
Change in share count Balance sheet -1.7% -0.0% 21 of 73
Days sales outstanding Balance sheet 54 days 63 days 19 of 65

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Health and Science Technologies $1.5B 43.1% ▲ 15.2%
Fluid and Metering Technologies $1.2B 35.4% ▼ 0.8%
Fire and Safety Diversified Products $744M 21.5% ▲ 0.2%
Geography
Region Revenue Share YoY
United States $1.8B 50.8% ▲ 8.6%
Europe $846M 24.4% ▲ 6.2%
Asia $563M 16.2% ▼ 1.4%
Other Geographical Areas $165M 4.8% ▲ 7.2%
North America Excluding United States $130M 3.7% ▼ 2.0%

From IDEX Corporation's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$17B
Institutions reporting
678
Shares held vs prior quarter
▲ 0.1%
Positions opened / closed
78 / 69

Top buyers and sellers, Q2 2026: 329 institutions bought and 275 sold ; the biggest buyer was Pictet Asset Management Holding SA (+607K shares) and the biggest seller Van Eck Associates Corp (−937K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.3B 5.7M 7.7% ▲ 1.0%
Vanguard Capital Management LLC $1.1B 4.8M 6.5% ▼ 0.2%
Vanguard Portfolio Management LLC $847M 3.7M 5.0% ▼ 0.9%
State Street Corp $753M 3.3M 4.4% ▲ 3.5%
Primecap Management Co $749M 3.3M 4.4% ▼ 0.1%
Morgan Stanley $640M 2.8M 3.8% ▼ 9.0%
Millennium Management LLC $538M 2.4M 3.2% ▲ 18.7%
Geode Capital Management, LLC $474M 2.1M 2.8% ▲ 0.3%
Nordea Investment Management AB $419M 1.8M 2.5% ▼ 1.7%
Victory Capital Management Inc $346M 1.5M 2.0% ▲ 0.9%
Invesco Ltd. $341M 1.5M 2.0% ▼ 7.7%
Amundi $331M 1.5M 1.9% ▲ 19.6%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not IDEX Corporation's complete shareholder register. Values are as reported by the filers ; 4 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $101,647 1 trade by 1 insider, last 12 months Insider sales History → $3.4M 3 trades by 2 insiders · 0% under pre-set plans
Net ▼ $3.3M net selling
Insider Date Trade Shares Price Value
Anderson Lisa M SVP, GC, CAO & Corp Sec August 12, 2026 Sell 385 $238.59 $91,859
Ashleman Eric D CEO and President May 11, 2026 Sell 4,915 $215.81 $1.1M
Ashleman Eric D CEO and President May 11, 2026 Sell 10,470 $214.95 $2.3M
Christenson Carl R Director November 5, 2025 Buy 600 $169.41 $101,647

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 7 trades and filings

No trades in IDEX Corporation disclosed in the last 12 months; 7 earlier trades on record.

  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 31, 2025, filed November 21, 2025
  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 30, 2025, filed November 21, 2025
  • Lisa C. McClain(R-MI 9):Purchase, $1,001 - $15,000, traded October 30, 2025, filed November 21, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 3, 2027 estimated from the company's past filing pattern, not announced

  • October 28, 2026
  • July 29, 2026
  • April 29, 2026
  • February 4, 2026
  • October 29, 2025
  • July 30, 2025

Recent SEC filings

Data status

When each part of this page on IDEX Corporation was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

IDEX Corporation in brief

What does IDEX Corporation do?
IDEX Corporation is a US-listed company in the industrial machinery & supplies & components industry. Its financial year ends in December.
What is IDEX Corporation's stock ticker?
IDEX Corporation trades under the ticker IEX on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is IDEX Corporation's revenue, and how fast is it growing?
Over its most recent trailing twelve months, IDEX Corporation reported revenue of $3.7B, 6.9% higher than a year earlier, according to its SEC filings.
What is IDEX Corporation's free cash flow?
IDEX Corporation's free-cash-flow margin is 18.2% of revenue over the trailing twelve months, ranking 11 of the 76 industrial machinery & supplies & components companies we cover.
What is IDEX Corporation's fair value (intrinsic value) per share?
Our discounted-cash-flow model of IDEX Corporation's free cash flow after stock-based pay gives ~$160 per share in the base case, and ~$110–$210 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are IDEX Corporation's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is IDEX Corporation buying back stock, and does it pay a dividend?
IDEX Corporation spent $301M on share repurchases over the trailing twelve months, and its diluted share count fell 1.7% over the year.
What is IDEX Corporation's market cap?
On November 2, 2026, IDEX Corporation's market capitalisation was about $17.6B, with a price-to-earnings ratio of 32.8 and net debt of $1.2B. Market figures come from third-party market data and may be delayed.
Does IDEX Corporation pay a dividend?
Yes: IDEX Corporation paid $214M in dividends over the trailing twelve months, a dividend yield of 1.22% and a payout ratio of 39.9%.
How much debt does IDEX Corporation have?
IDEX Corporation's debt-to-equity ratio is 43.6%, from its latest balance sheet (41.1% five years earlier). The financial health section below sets out its other solvency checks.
Who are IDEX Corporation's competitors?
In our Industrial Machinery & Supplies & Components peer group, the companies closest to IDEX Corporation are Gates Industrial Corp Ltd., Donaldson Co Inc, JBT Marel Corp, Middleby Corp and Pentair. The side-by-side comparison below sets their revenue, margins and growth against IDEX Corporation's.
Are insiders buying or selling IDEX Corporation stock?
Over the last 12 months, IDEX Corporation's directors and officers reported 1 open-market purchases and 3 sales on Form 4. The insider trading page charts every trade.
When is IDEX Corporation's next earnings date?
Around February 3, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — IDEX Corporation announces its own schedule.